Skip to main content
. 2015 Nov 25;2015(11):CD010576. doi: 10.1002/14651858.CD010576.pub2
  Intervention and comparator intervention Sex
 [female %] Age
 [mean years (CI/SD/range)] Comedications/Cointerventions Comorbidities
Barczynski 2012 I: total thyroidectomy 89 46.2 (CI 43.5 to 48.9) Antithyroid drugs/beta blockers
C: bilateral subtotal thyroidectomy 89 45.5 (CI 43.1 to 47.9)
Witte 2000 I: total thyroidectomy 82 38 (19 to 68) Antithyroid drugs/beta blockers (40%), thyroid hormone substitution (40.7%)
C1: bilateral subtotal thyroidectomy 86 35.5 (12 to 73)
C2: Dunhill procedure 82 41 (17 to 66)
Jarhult 2005 I: total thyroidectomy 95 44 (21 to 62) Antithyroid drugs for at least 3 months preoperatively
Postoperative thyroxine supplementation
5 participants in each group received cortisone to decrease the activity of the EO
C: subtotal thyroidectomy 86 42 (24 to 69)
Chi 2005 I: bilateral subtotal thyroidectomy 84 33.3 (SD 0.73) Propylthiouracil/methimazole
C: Dunhill procedure 87 34.5 (SD 0.93)
Muller 2001 I: bilateral subtotal thyroidectomy 30.8 (14 to 78) Antithyroid medication
C: Dunhill procedure 30.8 (14 to 78)
‐ denotes not reported
C: comparator; CI: confidence interval; EO: endocrine ophthalmopathy; I: intervention; SD: standard deviation